Substance in the blood of pregnant women fights pathological immune reaction

Digital providers come to the fore to support global mental health during pandemic
10 February 2021
‘Gamechanger’ drug for treating obesity cuts body weight by 20%
10 February 2021

Substance in the blood of pregnant women fights pathological immune reaction

A team of scientists from Immanuel Kant Baltic Federal University with their colleagues from the Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences (Perm) studied the effect of trophoblastic β1-glycoprotein in the blood of pregnant women on pro-inflammatory immune cells. Thanks to trophoblastic β1-glycoprotein, a woman’s body does not adversely react to the fetus and supports its normal development until birth. It turned out that trophoblastic β1-glycoproteins also suppressed the development of pro-inflammatory lymphocytes and reduced their activity. The results of the work could be used to develop medicinal drugs for pregnancy maintenance and treatment of various autoimmune diseases.

Comments are closed.